# Lurasidone

## Latuda 40mg

##### 

| TAH Drug Code      | OLAT                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Schizophrenia.                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | Should be taken with food (at least 350 kcal). Schizophrenia: 40mg QD. maximum: 160mg/day. Depressive episodes of type 1 bipolar disorder: 20mg QD, the dose can be increased based on clinical response after one week of treatment. maximum: 80mg/day.                                                                                                                 |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Hypersensitivity. Concomitant w/ strong CYP3A4 inhibitors (eg, ketoconazole, clarithromycin, ritonavir, voriconazole) & inducers (eg, rifampin, St. John's wort, phenytoin, carbamazepine).                                                                                                                                                                              |
| Adverse Effects    | Akathisia, somnolence. Hypersensitivity; increased wt; insomnia, agitation, anxiety, restlessness; parkinsonism, dizziness, dystonia, dyskinesia; nausea, vomiting, dyspepsia, salivary hypersecretion, upper abdominal pain, stomach discomfort; rash, pruritus; musculoskeletal stiffness, increased blood creatine phoshokinase; increased serum creatinine; fatigue. |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                             |

